Treatment

Mary Pieper
2 mins read - July 5, 2024

Frontiers in Oncology provisionally accepted a case report Friday suggesting the use of first-line nivolumab and ipilimumab could be more effective than chemotherapy in malignant...

Mary Pieper
2 mins read - May 30, 2024

The FDA has granted Priority Review designation to Merck’s application for Keytruda (pembrolizumab) plus chemotherapy as a first-line treatment for patients with advanced or...

Jean Brannum
3 mins read - May 18, 2024

For patients diagnosed with the aggressive cancer mesothelioma, the choice of surgical treatment has always been a complex decision. Historically, the radical surgery to remove an...

Mary Pieper
2 mins read - May 14, 2024

A recent study led by researchers at Harvard Medical School suggests women with pleural mesothelioma (PM) who undergo a lung-sparing surgery called intended extended pleurectomy...

Mary Pieper
3 mins read - May 2, 2024

In the ongoing battle against mesothelioma, the introduction of ADI-PEG20 (pegargiminase) marks a significant milestone. This innovative drug, hailed for its novel approach,...

Jean Brannum
2 mins read - December 24, 2023

Sellas Life Sciences, a prominent biopharmaceutical company in the U.S. focused on late-stage clinical developments, has recently announced encouraging results from its Phase I...

Amna Anees
2 mins read - October 9, 2023

A groundbreaking study led by researchers at The University of Texas at Austin introduces a novel drug that restores the effectiveness of immune cells in combating cancer....

Jean Brannum
2 mins read - February 14, 2022

A groundbreaking study led by researchers at Mayo Clinic Cancer Center in Florida is revolutionizing gastric cancer treatment by leveraging genomic sequencing to predict patient...

Amna Anees
2 mins read - February 14, 2022

A recent study, led by researchers at Yale Cancer Center and the University of Maryland Comprehensive Cancer Center, has revealed promising results in the treatment of...

Jean Brannum
2 mins read - December 16, 2021

In a groundbreaking discovery, researchers at Wake Forest School of Medicine have unveiled a nanoparticle therapeutic that revolutionizes cancer immunotherapy, offering a promising...

Jean Brannum
3 mins read - November 8, 2021

Researchers at the forefront of cancer immunotherapy have unveiled a groundbreaking treatment avenue for patients battling inoperable pleural mesothelioma, a lethal lung cancer. A...

Amna Anees
2 mins read - October 10, 2021

In the realm of mesothelioma treatment, immunotherapy emerges as a beacon of hope, with researchers striving to unravel its potential against this rare and aggressive disease....

Jean Brannum
2 mins read - August 12, 2021

Bioengineers at the University of California San Diego have pioneered a groundbreaking cancer immunotherapy that harnesses ultrasound technology to target and destroy malignant...

Amna Anees
3 mins read - July 14, 2021

In a groundbreaking Phase II study, spearheaded by experts from The University of Texas MD Anderson Cancer Center, a formidable duo of drugs, atezolizumab, and bevacizumab, has...

Cameron Ayers
2 mins read - April 23, 2021

Europe is poised to see a new first-line therapy for mesothelioma after getting the green light from a medical review agency.A division of the European Medicines Agency (EMA) —...

Patricia Shelton
2 mins read - April 14, 2021

An immunotherapy cocktail could aid relapsed mesothelioma patients without surgical options, according to a recent study.A team of Italian researchers reported that a combination...

Cameron Ayers
2 mins read - April 6, 2021

A remarkable computer model focused on decoding the complex genetic interactions found in pleural mesothelioma cases could give researchers insight into future treatments for the...

Cameron Ayers
3 mins read - March 24, 2021

An uncommon form of mesothelioma was the focus of two retrospective studies published this week: one focusing on untested treatments and the other on experimental gene research.The...

Amna Anees
2 mins read - March 16, 2021

While there are multiple methods for differentiating between benign and malignant mesothelioma cells, immunostaining the CD146 protein doesn’t appear to be one of them.That’s the...

Cameron Ayers
2 mins read - February 23, 2021

An immunotherapy candidate for mesothelioma continues to show promise in clinical trials, even before the trial has reached the halfway mark.Norwegian pharmaceutical company...